Kowald, S.; Huge, Y.; Tandiono, D.; Ali, Z.; Vazquez-Rodriguez, G.; Erkstam, A.; Fahlgren, A.; Sherif, A.; Cao, Y.; Jensen, L.D.
Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer. Cells 2023, 12, 508.
https://doi.org/10.3390/cells12030508
AMA Style
Kowald S, Huge Y, Tandiono D, Ali Z, Vazquez-Rodriguez G, Erkstam A, Fahlgren A, Sherif A, Cao Y, Jensen LD.
Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer. Cells. 2023; 12(3):508.
https://doi.org/10.3390/cells12030508
Chicago/Turabian Style
Kowald, Saskia, Ylva Huge, Decky Tandiono, Zaheer Ali, Gabriela Vazquez-Rodriguez, Anna Erkstam, Anna Fahlgren, Amir Sherif, Yihai Cao, and Lasse D. Jensen.
2023. "Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer" Cells 12, no. 3: 508.
https://doi.org/10.3390/cells12030508
APA Style
Kowald, S., Huge, Y., Tandiono, D., Ali, Z., Vazquez-Rodriguez, G., Erkstam, A., Fahlgren, A., Sherif, A., Cao, Y., & Jensen, L. D.
(2023). Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer. Cells, 12(3), 508.
https://doi.org/10.3390/cells12030508